Home » Newsletters » BioWorld

BioWorld

Aug. 6, 1991

View Archived Issues

FDA APPROVES TESTS OF IMRE'S PROSORBA

COLUMBIA FINALIZES MARKETING DEALS FOR REPLENS

VIMRX GETS FUNDING FOR AIDS DRUG

MMD PICKS LATIN AMERICAN DISTRIBUTOR

PTO ALLOWS ALL CORTEX'S SPECTRIN CLAIMS

FORMER AMGEN PRESIDENT HEADS START-UP

ATHENA TO CO-DEVELOP ALZHEIMER'S MODELS

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...